Analysis of the vasorelaxant action of angiotensin II in the isolated rat renal artery

Journal of Pharmacological Sciences

Volumn 106, Issue 3, 2008, Pages 376-384

  Grbović, Leposava ^a   Djokić, Jelena ^a   Radenković, Miroslav ^a   Pešić, Srdan ^b  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b UNIVERSITY OF NI   (Serbia)

Author keywords

Angiotensin II; AT receptor; K+ channel; Rat renal artery; Vasorelaxation

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN II; APAMIN; BARIUM; CHARYBDOTOXIN; GLIBENCLAMIDE; GUANYLATE CYCLASE; ICATIBANT; INDOMETACIN; LOSARTAN; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR; POTASSIUM CHANNEL; POTASSIUM CHANNEL BLOCKING AGENT; TETRYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENDOTHELIUM; MALE; NONHUMAN; RAT; RENAL ARTERY; VASODILATATION;

EID: 41549132115     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.FP0071268     Document Type: Article

References (42)

1. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev. 2000;52:415-472.
2. Saino A, Pomidossi G, Perondi R, Valentini R, Rimini A, Di Francesco L, et al. Intracoronary angiotensin II potentiates coronary sympathetic vasoconstriction in humans. Circulation. 1997;96:148-153.
3. Touyz RM, Schiffrin EL. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells. Pharmacol Rev. 2000;52:639-672.
4. Arima S, Endo Y, Yaoita H, Omata K, Ogawa S, Tsunoda K, et al. Possible role of P-450 metabolite of arachidonic acid in vasodilatator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole. J Clin Invest. 1997;100:2816-2823.
5. Katada J, Majima M. AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions. Br J Pharmacol. 2002;136:484-491.
6. Tirapelli CR, Fukada SY, de Godoy MAF, de Oliveira AM. Analysis of the mechanisms underlying the vasorelaxant action of angiotensin II in the isolated rat carotid. Life Sci. 2006;78:2676-2682.
7. Fukada SY, Tirapelli CR, de Godoy MA, de Oliveira AM. Mechanisms underlying the endothelium-independent relaxation induced by angiotensin II in rat aorta. J Cardiovasc Pharmacol. 2005;45:136-143.
8. Toda N, Miyazaki M. Angiotensin-induced relaxation in isolated dog renal and cerebral arteries. Am J Physiol. 1981;240:H247-H254.
9. Batenburg WW, Garrelds IM, Bernasconi CC, Juillerat-Jeanneret L, Van Kats JP, Saxena PR, et al. Angiotensin II type 2 receptor-mediated vasodilatation in human coronary microarteries. Circulation. 2004;109:2296-2301.
10. Hannan RE, Davis EA, Widdop RE. Functional role of angiotensin II AT2 receptor in modulation of AT1 receptor-mediated contraction in rat uterine artery: involvement of bradykinin and nitric oxide. Br J Pharmacol. 2003;140:987-995.
11. Ca) channels. Hypertension. 2001;37:301-307.
12. Israel A, Cierco M, Sosa B. Angiotensin AT(2) receptors mediate vasodepressor response to footshock in rats. Role of kinins, nitric oxide and prostaglandins. Eur J Pharmacol. 2000;394:103-108.
13. 2 receptor-mediated vasodilation in the heart: effect of myocardial infarction. Am J Physiol. 2001;281:H2590-H2596.
14. Wackenfors A, Vikman P, Nilsson E, Edvinsson L, Malmsjö M. Angiotensin II-induced vasodilatation in cerebral arteries is mediated by endothelium-derived hyperpolarizing factor. Eur J Pharmacol. 2006;531:259-263.
15. Matsubara H. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ Res. 1998;83:1182-1191.
16. 2 receptor mRNA expression and renal vasodilatation are increased in renal failure. Hypertension. 2001;38:669-673.
17. Grbovic L, Radenkovic M, Prostran M, Pesic S. Characterization of adenosine action in isolated rat renal artery. Possible role of adenosine A (2A) receptors. Gen Pharmacol. 2001;35:29-36.
18. 2 receptors. Br J Pharmacol. 1998;125:1429-1436.
19. Cosentino F, Savoia C, De Paolis P, Francia P, Russo A, Maffei A, et al. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonists. Am J Hypertens. 2005;18:493-499.
20. Yamaguchi K, Nishimura H. Angiotensin II-induced relaxation of fowl aorta. Am J Physiol. 1998;255:R591-R599.
21. 2 and angiotensin 1-7 receptors in the EDRF-dependent vasodilator effect of angiotensin II on the isolated mesenteric vascular bed of the rat. Br J Pharmacol. 2004;141:860-866.
22. Kimura T, Toda N, Noda Y, Okamura T. Mechanisms of relaxation induced by angiotensin II in isolated canine and human uterine arteries. J Cardiovasc Pharmacol. 2001;37:585-595.
23. 2 subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension. 2001;38:1150-1157.
24. Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP dependent protein kinase activates Ca2+-activated K+ channels in cerebral artery smooth muscle cells. Am J Physiol. 1993;265:C299-C303.
25. Sausbier M, Schubert R, Voigt V. Mechanisms of NO/cGMPdependent vasorelaxation. Circ Res. 2000;87:825-830.
26. Ishii K, Chang B, Kerwin JF Jr, Huang ZJ, Murad F. N omega-nitro- L-arginine: a potent inhibitor of endothelium-derived relaxing factor formation. Eur J Pharmacol. 1990;176:219-233.
27. Garthwaite J, Southam E, Boulton CL, Nielsen EB, Schmidt K, Mayer B. Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4] oxadiazolo[4,3-α]quinoxalin-1-one. Mol Pharmacol. 1995;48:184-188.
28. Lovren F, Triggle CR. Involvement of nitrosothiols, nitric oxide and voltage-gated K+ channels in photorelaxation of vascular smooth muscle. Eur J Pharmacol. 1998;347:215-221.
29. Andrews KL, Mcguire JJ, Triggle CR. A photosensitive vascular smooth muscle store of nitric oxide in mouse aorta: no dependence on expression of endothelial nitric oxide synthase. Br J Pharmacol. 2003;138:932-940.
30. Gohlke P, Pees C, Unger T. AT2 receptor stimulation increases aortic cyclic GMP in SHRSP by a kinin-dependent mechanism. Hypertension. 1998;31:349-355.
31. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol. 1994;267:F296-F302.
32. Wilcox CS, Deng X, Welch WJ. NO generation and action during changes in salt intake: roles of nNOS and macula densa. Am J Physiol. 1998;274:R1588-R1593.
33. Siragy HM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest. 1997;100:264-269.
34. Plane F, Garland CJ. Differential effects of acetylcholine, nitric oxide and levcromakalin on smooth muscle membrane potential and tone in the rabbit basilar artery. Br J Pharmacol. 1993;110:651-667.
35. Alexander SP, Mathie A, Peters JA. Guide to receptors and channels, 2nd edition. Br J Pharmacol. 2006;147 Suppl 3:S1-S180.
36. Bychkov R, Burnham MP, Richards GR, Edwards G, Weston AH, Feletou M, et al. Characterization of a charybdotoxinsensitive intermediate conductance Ca2+-activated K+ channel in porcine coronary endothelium: relevance to EDHF. Br J Pharmacol. 2002;137:1346-1354.
37. Tamargo J, Caballero R, Gomez R, Valenzuela C, Delpon E. Pharmacology of cardiac potassium channels. Cardiovasc Res. 2004;62:9-33.
38. 2 receptor mediated hypotension. J Hinn Hypenens. 2000;14:40-46.
39. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, et al. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest. 1999;104:925-935.
40. 1 receptor antagonist. J Biol Chem. 2001;276:39721-39726.
41. Baranov D, Armstead WM. Nitric oxide contributes to AT2 but not to AT1 angiotensin II receptor-mediated vasodilatation of porcine pial arteries and arterioles. Eur J Pharmacol. 2005;525:112-116.
42. De Godoy MA, Dunn S, Rattan S. Evidence for the role of angiotensin II biosynthesis in the rat internal anal sphincter tone. Gastroenterology. 2004;127:127-138.